Baricitinib/Dupilumab/UpadacitinibVarious toxicities and lack of efficacy: 8 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71776-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：83 / 83

相关论文

共 50 条

[31] Basiliximab/ciclosporin/sirolimusVarious toxicities and lack of efficacy: 8 case reports
Reactions Weekly, 2023, 1967 (1) : 89 - 90
[32] Baricitinib/ruxolitinibLack of efficacy and various toxicities: 6 case reports
Reactions Weekly, 2022, 1924 (1) : 114 - 114
[33] Filgotinib/tofacitinib/upadacitinibVarious toxicities: 5 case reports
Reactions Weekly, 2024, 2021 (1) : 199 - 199
[34] Multiple drugsVarious toxicities, drug interaction and lack of efficacy: 8 case reports
Reactions Weekly, 2022, 1899 (1) : 288 - 288
[35] Antiepileptic-drugs/temozolomideVarious toxicities and lack of efficacy: 8 case reports
Reactions Weekly, 2023, 1945 (1) : 65 - 65
[36] Dexamethasone/dupilumab/prednisoneKeratoconjunctivitis and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1899 (1) : 162 - 162
[37] AntibacterialsVarious toxicities and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1920 (1) : 45 - 45
[38] VoriconazoleVarious toxicities and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1965 (1) : 478 - 478
[39] AntineoplasticsVarious toxicities and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1983 (1) : 63 - 63
[40] AntineoplasticsVarious toxicities and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1940 (1) : 65 - 66

← 1 2 3 4 5 →